Document Detail


Myasthenia gravis: treatment with plasma exchange experiences over 10 years.
MedLine Citation:
PMID:  1822852     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Evaluation of the results of plasmapheresis therapy is reviewed on 160 patients suffering from myasthenia gravis. This new therapeutical procedure is considered very valuable: improvement can be achieved in 63% of the patients during the therapy, a further improvement in 30% after it. Plasmapheresis is especially effective for patients in respiratory crisis-prone state, for drug-resistant cases and for preparation patients for surgery. Plasma exchange therapy may be combined with other forms of immunosuppression with benefit. Thymectomy and plasma exchange are considered to be the main therapeutical procedures in myasthenia gravis.
Authors:
L Fornádi; R Horváth; A Szobor
Publication Detail:
Type:  Comparative Study; Journal Article    
Journal Detail:
Title:  Acta medica Hungarica     Volume:  48     ISSN:  0236-5286     ISO Abbreviation:  Acta Med Hung     Publication Date:  1991  
Date Detail:
Created Date:  1992-09-08     Completed Date:  1992-09-08     Revised Date:  2006-11-15    
Medline Journal Info:
Nlm Unique ID:  8400269     Medline TA:  Acta Med Hung     Country:  HUNGARY    
Other Details:
Languages:  eng     Pagination:  137-44     Citation Subset:  IM    
Affiliation:
Dept. of Neurology, Ferenc Jahn Teaching Hospital, Budapest.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Follow-Up Studies
Humans
Immunosuppression
Myasthenia Gravis / therapy*
Plasmapheresis*
Retrospective Studies
Treatment Outcome

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Parkinson's syndrome: cranial computed-tomography findings. Their dependence on sex and age.
Next Document:  Prenatal cytogenetic study of translocation carriers.